Insider trades
Shannon Thyme Klinger, CLO of Moderna MRNA, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $899.6K. The latest trade was on 06/05.
Shannon Thyme Klinger
Chief Legal Officer
- Company
- Moderna MRNA
- First filing
- 23/03/02
- Trades
- 166 trades
- Buys / sales
- 0 / 24
- 12-month net buying
- −$899.6K
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ModernaMRNA | Open-market sale10b5-1 plan | 06/04 | 06/08 | 3,471 sh | $50.00 | $173,550 | −4.9% |
ModernaMRNA | Open-market sale10b5-1 plan | 03/02 | 03/03 | 13,885 sh | $52.29 | $726,046.65 | −18.9% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/12/09 | 24/12/10 | 529 sh | $44.68 | $23,635.72 | −2.5% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/12/03 | 24/12/04 | 112 sh | $43.30 | $4,849.6 | −0.6% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/11/29 | 24/12/02 | 1,418 sh | $42.79 | $60,676.22 | −6.7% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/09/09 | 24/09/10 | 551 sh | $73.57 | $40,537.07 | −2.9% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/09/03 | 24/09/04 | 114 sh | $76.99 | $8,776.86 | −0.6% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/08/29 | 24/08/30 | 162 sh | $78.03 | $12,640.86 | −0.9% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/08/28 | 24/08/29 | 1,319 sh | $79.39 | $104,715.41 | −7.1% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/06/10 | 24/06/11 | 5,178 sh | $148.09 | $766,810.02 | −24.5% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/06/03 | 24/06/04 | 122 sh | $140.72 | $17,167.84 | −1.1% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/05/29 | 24/05/30 | 183 sh | $144.50 | $26,443.5 | −1.7% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/05/28 | 24/05/29 | 1,296 sh | $162.47 | $210,561.12 | −10.9% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/03/08 | 24/03/11 | 544 sh | $99.05 | $53,883.2 | −5.5% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/03/04 | 24/03/05 | 117 sh | $94.34 | $11,037.78 | −1.3% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/02/29 | 24/03/01 | 670 sh | $94.57 | $63,361.9 | −7.3% |
ModernaMRNA | Open-market sale10b5-1 plan | 23/12/08 | 23/12/11 | 563 sh | $79.09 | $44,527.67 | −6.6% |
ModernaMRNA | Open-market sale10b5-1 plan | 23/12/04 | 23/12/05 | 111 sh | $79.31 | $8,803.41 | −1.5% |
ModernaMRNA | Open-market sale10b5-1 plan | 23/09/08 | 23/09/11 | 557 sh | $107.22 | $59,721.54 | −7.2% |
ModernaMRNA | Open-market sale10b5-1 plan | 23/09/05 | 23/09/06 | 115 sh | $111.44 | $12,815.6 | −1.7% |